Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.
about
Effect of Sensorineural Hearing Loss on Neurocognitive Functioning in Pediatric Brain Tumor Survivors.High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors.Analysis of childhood brain tumour data in New York City using frailty models.Carboplatin-based primary chemotherapy for infants and young children with CNS tumorsThe role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors: a reappraisal.Treatment of atypical central neurocytoma in a child with high dose chemotherapy and autologous stem cell rescue.Challenges of Treating Childhood Medulloblastoma in a Country With Limited Resources: 20 Years of Experience at a Single Tertiary Center in MalaysiaTreatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.Successful treatment of early detected trilateral retinoblastoma using standard infant brain tumor therapyPharmacokinetics of high-dose chemotherapy.Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma.Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors.Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours.Recent advances in the treatment of childhood brain tumors.The role of high-dose myeloablative chemotherapy with haematopoietic stem cell transplantation (HSCT) in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysisLate effects in survivors of childhood CNS tumors treated on Head Start I and II protocols.Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.Initial management of childhood brain tumors: neurosurgical considerations.A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Atypical Teratoid/Rhabdoid TumorPilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group.Pediatric brain tumors: current treatment strategies and future therapeutic approachesTandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents.Ependymoma: an update.Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials.Long-term follow-up of endocrine function among young children with newly diagnosed malignant central nervous system tumors treated with irradiation-avoiding regimens.A pilot trial of tandem autologous peripheral blood progenitor cell transplantation following high-dose thiotepa and carboplatin in children with poor-risk central nervous system tumors.High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702).Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease.Preliminary results of dose intensive pre-irradiation chemotherapy in patients older than 10 years of age with high risk medulloblastoma and supratentorial primitive neuroectodermal tumors.High-grade glioma in very young children: a rare and particular patient population.Medulloblastoma in infants: the critical issues of the dilemma.Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumors.Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the 'Head Start' trials, 1991-2009.Tandem high-dose chemotherapy and auto-SCT for malignant brain tumors in children under 3 years of age.Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation in pediatric patients with malignant brain tumors.Radiotherapy after high-dose chemotherapy with autologous hematopoietic cell rescue: Quality assessment of Head Start III.Desmoplastic Nodular Medulloblastoma in Young Children: A Management Dilemma.
P2860
Q30700156-175467F8-4D4F-4B9B-AF4C-BAE084D957ABQ31418305-27C54D45-A358-4FB4-AA62-641594DBD6E7Q32048746-C510A3C4-04BE-44D3-BAC1-5CC7155367CEQ33384747-632729D2-25E1-44C3-A02F-2CFF4D80E75DQ33788218-9D1EBA85-582D-41D5-A5F9-5E3D51C57C44Q33805151-DF38A9B2-C9A1-43DE-B9ED-D0DA819016C5Q33859754-4A96AD07-50AF-43E3-9A67-DE92CE356D16Q35021335-A3862822-8E3C-4D61-90A8-0FF579A2E93DQ35047241-B1C160F5-6DA1-4115-ACA2-A02E76A3B13BQ35597047-3EABEFC6-ABC0-4BD2-ACD9-FDDD95BE6D27Q35730809-21476441-74B0-4B76-9A67-F394BF673129Q35799863-E942C092-752F-47E6-A8D9-9CFFE271DF9DQ35988515-A79F16B8-9552-4809-9F95-CA67A2898318Q36090210-5D065E43-3B06-4712-86B0-76763443561EQ36195156-5B1D9BF8-46C1-432B-BDD8-F63F5777E02CQ36303975-4058CA8D-CBF0-4483-B281-5D13D0322D20Q36467511-E0CD0893-85C5-481F-B568-09E6A22477E6Q36544096-5B11751F-0CA2-4805-8832-47EE9EC1AC65Q36627160-B9F48D50-A817-44B0-9A40-2DB080E3339AQ37023302-D72266DF-747E-4F26-99AF-7F4CB9D2C7BCQ37284226-AE20AEB0-37BD-4000-A13F-4A658D5895AEQ37367443-819A5058-15C7-43CB-9CC8-5C43BBE0FF9BQ37514290-E6114DBC-1F84-4758-9DA7-1137EE74C325Q37533670-A168A2A8-4A97-403F-985D-299951535B54Q37570127-94615102-A1A5-4107-A6FF-685C08922073Q37617847-844A3CDA-8045-400B-85F5-F9DF3DC8E3F8Q38873292-757A30C7-B941-4E89-954D-7B834AF490ABQ39285777-CEA0D21D-8B86-45C4-9C6E-A4D0BB9931A6Q40518066-4CA4679B-DF4E-4D2C-9403-8D06F6703621Q40744398-EE44CF6B-C8BB-4404-B528-ED88C6611288Q41003114-F41C5D17-6F44-4285-9F95-590039C7B9BCQ42163502-A7CA6070-7953-4D94-BFD2-AA7D853C54FDQ42362800-0EB333E7-9AC2-4C32-AD6C-3F08984E3825Q42760993-11F974D1-69AC-4DB4-8E39-F44EE1C89741Q42785394-CC8B886B-8F17-499A-9A9C-10BDAEEA7E92Q44603483-16F792F0-4A52-45C9-A201-368A1C8F82B9Q45748713-E90CD8E4-8ECE-4001-AD78-8538A9108B38Q45952870-B86A7F16-415C-468C-941C-F96AA1E3EC50Q46489853-DCA96FAB-C8F6-4802-BDD5-108C4656B572Q47284266-1B0404D9-6686-4300-8E80-B44B3A4DE9FC
P2860
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Intensive chemotherapy and bon ...... gnosed malignant brain tumors.
@ast
Intensive chemotherapy and bon ...... gnosed malignant brain tumors.
@en
type
label
Intensive chemotherapy and bon ...... gnosed malignant brain tumors.
@ast
Intensive chemotherapy and bon ...... gnosed malignant brain tumors.
@en
prefLabel
Intensive chemotherapy and bon ...... gnosed malignant brain tumors.
@ast
Intensive chemotherapy and bon ...... gnosed malignant brain tumors.
@en
P2093
P1476
Intensive chemotherapy and bon ...... gnosed malignant brain tumors.
@en
P2093
B O'Malley
D Puccetti
I J Dunkel
J L Finlay
K Lindsley
P304
P356
10.1200/JCO.1998.16.1.210
P407
P50
P577
1998-01-01T00:00:00Z